biotech

Heparanase Inhibitor, Potential Anti-Cancer Drug Candidate

Filed in archive Drugs, Vaccines and Therapeutics on October 23, 2007

Heparanase Inhibitor, Potential Anti-Cancer Drug Candidate
An enzyme called heparanase which is produced by cancer cells has been linked in previous studies to malignancy. A recent study published in Nature Chemical Biology indicates that an inhibitor for heparanase may have potentials as an anti-cancer drug candidate.
Heparanase helps cancer cells make their way through tissue barriers, but it also stimulates the heightened generation of blood vessels that is necessary for tumor growth. The fragments function as carriers of growth factors that can promote tumor growth in many ways.


Source: Uppsala University

Permalink: Heparanase Inhibitor, Potential Anti-Cancer Drug Candidate

Tags: cancer  enzymes  heparanase  drug  biotech  cancer+drug  anti+cancer  drug+candidate 

Vote for Heparanase Inhibitor, Potential Anti-Cancer Drug Candidate:

  • Currently 6.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.00 out of 1 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Tagcloud
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells